Article (Périodiques scientifiques)
Treatment of mucocutaneous presentations of herpes simplex virus infections.
Nikkels, Arjen; Pierard, Gérald
2002In American Journal of Clinical Dermatology, 3 (7), p. 475-87
Peer reviewed vérifié par ORBi
 

Documents


Texte intégral
TREATMENT MUCOCUTANEOUS.pdf
Postprint Éditeur (592.97 kB)
Demander un accès

Tous les documents dans ORBi sont protégés par une licence d'utilisation.

Envoyer vers



Détails



Mots-clés :
Acantholysis/drug therapy; Antiviral Agents/therapeutic use; Burns/complications; Erythema Multiforme/virology; Herpes Genitalis/drug therapy; Herpes Labialis/drug therapy; Herpes Simplex/drug therapy/etiology; Humans; Infant, Newborn; Infant, Newborn, Diseases/drug therapy; Postoperative Complications; Recurrence; Skin/injuries; Ultraviolet Rays/adverse effects
Résumé :
[en] Infections by herpes simplex virus (HSV) types I and II are diverse and quite frequent. After primary infection, the virus establishes a life-long latency in the sensory ganglia and recrudescences may occur at an unpredictable rate. Recurrent labial and genital herpes infections represent the majority of clinical manifestations of HSV infections. Their management is currently well established using evidence-based medicine data. Primary labial herpes is generally not treated with antivirals in otherwise healthy children, although intravenous aciclovir may be offered in severe primary infections, particularly in the immunocompromised patient. The decision whether or not to treat recurrent labial herpes should be evaluated individually and depends on the frequency and severity of relapses, the impairment of the quality of life, and the cost of therapy. Patients with mild disease may benefit from topical therapy, and those with severe and frequent recurrences may be considered for intermittent or long-term oral antiviral therapy. Primary genital herpes is treated with oral or intravenous antivirals, depending on the severity of the infection and associated symptoms. Recurrent genital herpes can be managed with episodic short courses of oral antivirals in patients whose recurrences are moderate to severe and rare, and have a clear prodrome. Patients with >5 episodes/year, severe recurrences or unrecognisable prodromes may be best managed with long-term suppressive antiviral prophylaxis. HSV is also responsible for a variety of other clinical manifestations, including herpetic whitlow, neonatal infection, disseminated and atypical cutaneous infections, traumatic herpes, eczema herpeticum, and HSV-associated erythema multiforme. HSV infection may also represent a complication following cosmetic procedures of the oro-facial region, surgical and dental interventions, sun exposure and burns. Precise treatment guidelines for these HSV infections are not firmly established.
Disciplines :
Dermatologie
Auteur, co-auteur :
Nikkels, Arjen ;  Université de Liège - ULiège > Dermatologie
Pierard, Gérald ;  Université de Liège - ULiège > Dermatopathologie
Langue du document :
Anglais
Titre :
Treatment of mucocutaneous presentations of herpes simplex virus infections.
Date de publication/diffusion :
2002
Titre du périodique :
American Journal of Clinical Dermatology
ISSN :
1175-0561
eISSN :
1179-1888
Maison d'édition :
Adis International, Auckland, Nouvelle-Zélande
Volume/Tome :
3
Fascicule/Saison :
7
Pagination :
475-87
Peer reviewed :
Peer reviewed vérifié par ORBi
Disponible sur ORBi :
depuis le 25 mars 2009

Statistiques


Nombre de vues
188 (dont 6 ULiège)
Nombre de téléchargements
3 (dont 2 ULiège)

citations Scopus®
 
60
citations Scopus®
sans auto-citations
48
OpenCitations
 
45
citations OpenAlex
 
70

Bibliographie


Publications similaires



Contacter ORBi